Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the outcome of the FDA investigation into Smiths Medical by end of 2024?
Fine imposed • 25%
Additional recalls • 25%
No further action • 25%
Other • 25%
FDA official reports and announcements
FDA Classifies Smiths Medical Tracheostomy Tubes Recall as Most Serious, 35 Injuries and 2 Deaths Reported
Sep 19, 2024, 05:40 PM
The U.S. Food and Drug Administration (FDA) has classified the recall of certain Bivona neonatal/pediatric and adult tracheostomy tubes made by Smiths Medical, a unit of ICU Medical, as the most serious type. This classification indicates that the defect could cause severe injury or death. The recall, which involves the removal of these tubes due to a manufacturing defect, has been linked to 35 reported injuries and two deaths. The FDA's action underscores the critical nature of the manufacturing defect in these medical devices.
View original story
No action taken • 25%
Fine imposed • 25%
Production halted • 25%
Other • 25%
No action taken • 25%
Fines imposed • 25%
Production halted • 25%
Other • 25%
Safety concerns resolved • 25%
Further investigation required • 25%
Vaccine trials permanently halted • 25%
Other outcome • 25%
Fines imposed • 25%
Regulations introduced • 25%
No action taken • 25%
Other • 25%
Clinical hold lifted with no changes • 25%
Clinical hold lifted with additional requirements • 25%
Clinical hold maintained • 25%
Clinical hold converted to full stop • 25%
No issues found • 25%
Minor issues found • 25%
Moderate issues found • 25%
Severe issues found • 25%
Amina Abakarova found guilty • 25%
Amina Abakarova found not guilty • 25%
Investigation inconclusive • 25%
Other outcome • 25%
No further action • 25%
Fines imposed • 25%
Permanent ban on products • 25%
Other regulatory actions • 25%
Plant cleared and allowed to reopen • 25%
Plant permanently closed • 25%
Plant fined and required to make changes • 25%
Other outcome • 25%
No action taken • 25%
Warning issued • 25%
Fine imposed • 25%
License restrictions • 25%
No further action • 25%
Additional fines • 25%
Settlement reached • 25%
Criminal charges • 25%
Fines imposed • 25%
Regulations introduced • 25%
No action taken • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No significant impact • 25%
Other • 25%
Revenue decrease > 10% • 25%
Revenue decrease ≤ 10% • 25%